Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Tissue Factor Pathway Inhibitor Modulates Endothelial and Vascular Smooth Muscle Cell Functions By Drifting Cellular Phenotypes

Vanessa Bröker, Jarno JJ Koetsier, Stella Thomassen, Elisabetta Castoldi, Kanin Wichapong, Philip Wenzel, Leon Schurgers, Tilman M. Hackeng

Blood (2024) 144 (Supplement 1): 3987.

https://doi.org/10.1182/blood-2024-203403

Published: 2024

Journal Articles

Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel FGG Mutation

Amaury Monard, Floor Moenen, Elisabetta Castoldi, Ilaria De Simone, Paola Van Der Meijden, Kanin Wichapong, William van Doorn, Stefano Spada, Dave Hellenbrand, Alexander Stork, Hugo Ten Cate, Erik AM Beckers, Yvonne Henskens

Blood (2023) 142 (Supplement 1): 5471.

https://doi.org/10.1182/blood-2023-181894

Published: 2023

Journal Articles

Making sense of FV short

Elisabetta Castoldi

Blood (2023) 141 (26): 3134–3135.

https://doi.org/10.1182/blood.2023020274

Published: 2023

Journal Articles

A Novel Quali-Quantitative Defect of VWF

Tom Van De Berg, Alice Todaro, Joyce van Beers, Kanin Wichapong, Floor Heubel-Moenen, Elisabetta Castoldi, Yvonne M.C. Henskens, Erik AM Beckers

Blood (2021) 138 (Supplement 1): 1032.

https://doi.org/10.1182/blood-2021-147899

Published: 2021

Journal Articles

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

Paolo Simioni, Stefano Cagnin, Francesca Sartorello, Gabriele Sales, Luca Pagani, Cristiana Bulato, Sabrina Gavasso, Francesca Nuzzo, Francesco Chemello, Claudia M. Radu, Daniela Tormene, Luca Spiezia, Tilman M. Hackeng, Elena Campello, Elisabetta Castoldi

Blood (2021) 137 (17): 2383–2393.

https://doi.org/10.1182/blood.2020008168

Published: 2021

Includes: Supplemental data

Journal Articles

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

Tilman M. Hackeng, PhD, Peter van Doorn, MSc, Jan Rosing, PhD, Joost Meijers, PhD, Saskia Middeldorp, MD PhD, Paolo Simioni, MD PhD, Elisabetta Castoldi, PhD

Blood (2018) 132 (Supplement 1): 1168.

https://doi.org/10.1182/blood-2018-99-118767

Published: 2018

Journal Articles

The C-Terminus of Tfpiα Inhibits Factor V Activation By Protecting the Arg 1545 Cleavage Site

Peter van Doorn, Msc, Jan Rosing, PhD, Simone Wielders, Tilman M. Hackeng, PhD, Elisabetta Castoldi, PhD

Blood (2016) 128 (22): 257.

https://doi.org/10.1182/blood.V128.22.257.257

Published: 2016

Journal Articles

New Functional Assays to Selectively Quantify APC- and TFPI-Cofactor Activities of Protein S in Plasma

Nahla Alshaikh, Msc, Jan Rosing, PhD, Stella Thomassen, Elisabetta Castoldi, PhD, Paolo Simioni, MD PhD, Tilman M. Hackeng, PhD

Blood (2016) 128 (22): 717.

https://doi.org/10.1182/blood.V128.22.717.717

Published: 2016

Journal Articles

Effect of Five Therapeutic Strategies on the Coagulation Defect Induced By the Thrombomodulin C.1611C>a Mutation

Yesim G. Dargaud, MDPhD, Yohann Jourdy, Sandra Le Quellec, Coen Hemker, Theo Lindhout, Elisabetta Castoldi, Claude Negrier, MD

Blood (2015) 126 (23): 2287.

https://doi.org/10.1182/blood.V126.23.2287.2287

Published: 2015

Journal Articles

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation

Yesim Dargaud, Jean Yves Scoazec, Simone J. H. Wielders, Christine Trzeciak, Tilman M. Hackeng, Claude Négrier, H. Coenraad Hemker, Theo Lindhout, Elisabetta Castoldi

Blood (2015) 125 (9): 1497–1501.

https://doi.org/10.1182/blood-2014-10-604553

Published: 2015

Journal Articles

Fibrinogen γ′ increases the sensitivity to activated protein C in normal and factor V Leiden plasma

Farida Omarova, Shirley Uitte de Willige, Paolo Simioni, Robert A. S. Ariëns, Rogier M. Bertina, Jan Rosing, Elisabetta Castoldi

Blood (2014) 124 (9): 1531–1538.

https://doi.org/10.1182/blood-2014-02-554055

Published: 2014

Journal Articles

FV and APC resistance: the plot thickens

Elisabetta Castoldi

Blood (2014) 123 (15): 2288–2289.

https://doi.org/10.1182/blood-2014-02-557363

Published: 2014

Journal Articles

Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation

Francesca Nuzzo, Claudia Radu, Marco Baralle, Luca Spiezia, Tilman M. Hackeng, Paolo Simioni, Elisabetta Castoldi

Blood (2013) 122 (23): 3825–3831.

https://doi.org/10.1182/blood-2013-04-499657

Published: 2013

Includes: Supplemental data

Journal Articles

Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome

Elisabetta Castoldi, Peter W. Collins, Patrick L. Williamson, Edouard M. Bevers

Blood (2011) 117 (16): 4399–4400.

https://doi.org/10.1182/blood-2011-01-332502

Published: 2011

Journal Articles

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

Connie Duckers, Paolo Simioni, Luca Spiezia, Claudia Radu, Paolo Dabrilli, Sabrina Gavasso, Jan Rosing, Elisabetta Castoldi

Blood (2010) 115 (4): 879–886.

https://doi.org/10.1182/blood-2009-08-237719

Published: 2010

Journal Articles

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

Marina Marchetti, Elisabetta Castoldi, Henri M. H. Spronk, René van Oerle, Donatella Balducci, Tiziano Barbui, Jan Rosing, Hugo ten Cate, Anna Falanga

Blood (2008) 112 (10): 4061–4068.

https://doi.org/10.1182/blood-2008-06-164087

Published: 2008

Journal Articles

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

Connie Duckers, Paolo Simioni, Luca Spiezia, Claudia Radu, Sabrina Gavasso, Jan Rosing, Elisabetta Castoldi

Blood (2008) 112 (9): 3615–3623.

https://doi.org/10.1182/blood-2008-06-162453

Published: 2008

Journal Articles

An underestimated combination of opposites resulting in enhanced thrombotic tendency

Paolo Simioni, Elisabetta Castoldi, Barbara Lunghi, Daniela Tormene, Jan Rosing, Francesco Bernardi

Blood (2005) 106 (7): 2363–2365.

https://doi.org/10.1182/blood-2005-04-1461

Published: 2005

Journal Articles

Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations

Elisabetta Castoldi, Jeroen M. Brugge, Gerry A. F. Nicolaes, Domenico Girelli, Guido Tans, Jan Rosing

Blood (2004) 103 (11): 4173–4179.

https://doi.org/10.1182/blood-2003-10-3578

Published: 2004

Journal Articles

Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation

Elisabetta Castoldi, José W. P. Govers-Riemslag, Mirko Pinotti, Debora Bindini, Guido Tans, Mauro Berrettini, Maria Gabriella Mazzucconi, Francesco Bernardi, Jan Rosing

Blood (2003) 102 (12): 4014–4020.

https://doi.org/10.1182/blood-2003-04-1199

Published: 2003

NARROW

Tissue Factor Pathway Inhibitor Modulates Endothelial and Vascular Smooth Muscle Cell Functions By Drifting Cellular Phenotypes

Evaluation of Innovative Laboratory Tests to Predict a Thrombotic Phenotype in a Family with Dysfibrinogenemia and a Novel FGG Mutation

Making sense of FV short

A Novel Quali-Quantitative Defect of VWF

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

The C-Terminus of Tfpiα Inhibits Factor V Activation By Protecting the Arg 1545 Cleavage Site

New Functional Assays to Selectively Quantify APC- and TFPI-Cofactor Activities of Protein S in Plasma

Effect of Five Therapeutic Strategies on the Coagulation Defect Induced By the Thrombomodulin C.1611C>a Mutation

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation

Fibrinogen γ′ increases the sensitivity to activated protein C in normal and factor V Leiden plasma

FV and APC resistance: the plot thickens

Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation

Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency

An underestimated combination of opposites resulting in enhanced thrombotic tendency

Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations

Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only